News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation


5/8/2014 6:58:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca's shares climbed nearly 2pc on Thursday morning, in a sign investors are expecting a renewed offer from US giant Pfizer. The rise follows three trading days of falls after AstraZeneca rebuffed Pfizer's second cash-and-shares offer on Friday. Pfizer's bid was worth around £63bn at the time, but the value has fallen to around £60bn due to a slide in Pfizer's share price after it posted a 15pc fall in profits for the first quarter of the year.

Help employers find you! Check out all the jobs and post your resume.

Read at Telegraph


comments powered by Disqus
Telegraph
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES